Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) EBITDA Margin Growth (1y) (2010 - 2026)

Analysis

Revvity (RVTY) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 50.00
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 519.00
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 293.00
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 93.00
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -36.00
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 3,065.00
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -68.00
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn -77.00
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn -3,037.00
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -928.00
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 -36.00
Apr 5, 2026 -19.00
Dec 28, 2025 -181.00
Sep 28, 2025 -263.00
Jun 29, 2025 21.00
Mar 30, 2025 408.00
Sep 29, 2024 403.00
Jun 30, 2024 139.00
Mar 31, 2024 -449.00
Oct 1, 2023 -524.00
Jul 2, 2023 -1,495.00
Apr 2, 2023 -1,592.00
Jan 1, 2023 -1,063.00
Oct 2, 2022 -714.00
Jul 3, 2022 -786.00
Apr 3, 2022 -1,707.00
Jan 2, 2022 -849.00
Oct 3, 2021 -302.00
Jul 4, 2021 1,218.00
Apr 4, 2021 3,742.00